TrialArthritis research & therapy2011

Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.

Hanns-Martin Lorenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.